数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Sylvia A. Wulf 女 Chair of the Board 68 6.00万 3.39 2025-10-28
Graydon Bensler 男 Director 34 0.83万 未持股 2025-10-28
Braeden Lichti 男 Director 41 0.83万 未持股 2025-10-28
Rick L. Sterling 男 Director 62 5.63万 0.33 2025-10-28

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
David A. Frank 男 Interim Chief Executive Officer,CFO and Treasurer 66 33.48万 1.51 2025-10-28

董事简历

中英对照 |  中文 |  英文
Sylvia A. Wulf

SylviaA.Wulf,首席执行官兼总裁。Wulf女士于2019年1月1日被任命为Aquabounty的执行董事,总裁兼首席执行官。在加入Aquabounty之前,伍尔夫女士曾担任美国食品公司(US Foods,Inc.)的高级副总裁,自2011年6月起担任该公司制造部门总裁。在加入US Foods之前,Wulf女士曾在泰森食品公司、Sara Lee Corporation和Bunge Corp.担任高级职位。她目前也在the National Fisheries Institute的董事会和执行委员会任职。选择Wulf女士是因为她在北美食品行业的经验,包括其渔业部门。Wulf女士在西伊利诺伊大学(Western Illinois University)获得金融学学士学位,并在德保罗大学(DePaul University)获得工商管理硕士学位。


Sylvia A. Wulf,was elected Chair of the Board of AquaBounty in 2023. She was Executive Director, President, and CEO of AquaBounty from 2019 to 2023. In 2023 she relinquished her position as President but remained as CEO until 2024. She is currently Interim Head, Agriculture and Environment at the Biotechnology Innovation Organization. Prior to joining AquaBounty, Ms. Wulf served as a Senior Vice President of US Foods, Inc. (NYSE:USFD), where she had been President of the Manufacturing Division since June 2011. Prior to US Foods, Ms. Wulf held senior positions in Tyson Foods, Inc. (NYSE:TSN), Sara Lee Corporation, and Bunge Corp (NYSE:BG). She is also currently on the Board of Directors and the Executive Committee of both the National Fisheries Institute and the Biotechnology Innovation Organization. Ms. Wulf received a Bachelor of Science in Finance from Western Illinois University and a Master of Business Administration from DePaul University.
SylviaA.Wulf,首席执行官兼总裁。Wulf女士于2019年1月1日被任命为Aquabounty的执行董事,总裁兼首席执行官。在加入Aquabounty之前,伍尔夫女士曾担任美国食品公司(US Foods,Inc.)的高级副总裁,自2011年6月起担任该公司制造部门总裁。在加入US Foods之前,Wulf女士曾在泰森食品公司、Sara Lee Corporation和Bunge Corp.担任高级职位。她目前也在the National Fisheries Institute的董事会和执行委员会任职。选择Wulf女士是因为她在北美食品行业的经验,包括其渔业部门。Wulf女士在西伊利诺伊大学(Western Illinois University)获得金融学学士学位,并在德保罗大学(DePaul University)获得工商管理硕士学位。
Sylvia A. Wulf,was elected Chair of the Board of AquaBounty in 2023. She was Executive Director, President, and CEO of AquaBounty from 2019 to 2023. In 2023 she relinquished her position as President but remained as CEO until 2024. She is currently Interim Head, Agriculture and Environment at the Biotechnology Innovation Organization. Prior to joining AquaBounty, Ms. Wulf served as a Senior Vice President of US Foods, Inc. (NYSE:USFD), where she had been President of the Manufacturing Division since June 2011. Prior to US Foods, Ms. Wulf held senior positions in Tyson Foods, Inc. (NYSE:TSN), Sara Lee Corporation, and Bunge Corp (NYSE:BG). She is also currently on the Board of Directors and the Executive Committee of both the National Fisheries Institute and the Biotechnology Innovation Organization. Ms. Wulf received a Bachelor of Science in Finance from Western Illinois University and a Master of Business Administration from DePaul University.
Graydon Bensler

Graydon Bensler,自Elevai Labs,Inc.成立以来一直担任Elevai Labs,Inc.的首席财务官。Bensler先生是一名金融专业人士和分析师,在私营企业和美国/加拿大上市公司的金融咨询和管理方面拥有超过七年的经验,并且是一名特许金融分析师(CFA)。2017年,本斯勒与他人共同创立了一家教育科技课程管理和安排公司,该公司被植入加拿大和美国的学术学校。从2017年到2019年,本斯勒在一家领先的加拿大投资者关系公司担任客户经理,在那里他代表各行各业的上市公司,直接与投资银行、投资经纪人以及公司高管和董事合作。在任职期间,本斯勒创建并传达了有关其客户在市场中的战略地位的信息,并成功地指导了多家公司通过多次融资。从2019年到2021年,本斯勒在加拿大精品投行Evans & Evans担任高级助理,负责加拿大和美国公司的估值和上市交易。在担任这一职务期间,本斯勒先生对资本市场、上市公司合规要求有了很深的了解,并定期与监管机构、审计员、董事会和执行管理层进行交流。自2020年以来,本斯勒还担任上市公司Health Logic Interactive Inc.(TSXv:CHIP)的董事。我们相信,Bensler先生过去担任Elevai Labs,Inc. 首席财务官的经验,他对银行和金融咨询行业的熟悉,以及他曾在类似情况的公司担任客户经理,使他成为Elevai Labs,Inc.公司的合格董事。本斯勒在西安大略大学获得管理和组织研究学士学位,专攻金融,是CFA特许持有人。


Graydon Bensler has served as Pmgc Holdings Inc.'s Chief Executive Officer since June 2024 and Chief Financial Officer since inception and a director since June 9, 2020. Mr. Bensler is a financial professional and analyst with over eight years of experience in financial consulting and management for both private businesses and US/Canadian publicly traded companies and is a CFA Charterholder (CFA). Mr. Bensler is the founder and sole owner of GB Capital Ltd, a privately held holding company he founded in 2019 and which company is engaged in capital markets advisory, financial consulting, and management. In 2017, Mr. Bensler co founded an education technology curriculum management and scheduling company that was implemented in academic schools in Canada and the United States. From 2017 to 2019, Mr. Bensler was an account manager at a leading Canadian investor relations firm where he represented publicly traded companies across a wide range of sectors and worked directly with investment banks, investment brokers and company executives and directors. During his tenure at this investor relations firm, Mr. Bensler created and conveyed messaging about his clients' strategic position in the market and successfully guided several companies through multiple financings. From 2019 to 2021, Mr. Bensler was a Senior Associate at Evans & Evans, a Canadian boutique investment banking firm where he led valuations and going public transactions for Canadian and United States companies. In this capacity, Mr. Bensler gained strong knowledge of the capital markets, public company compliance requirements, and regularly interfaced with regulators, auditors, board and executive management.
Graydon Bensler,自Elevai Labs,Inc.成立以来一直担任Elevai Labs,Inc.的首席财务官。Bensler先生是一名金融专业人士和分析师,在私营企业和美国/加拿大上市公司的金融咨询和管理方面拥有超过七年的经验,并且是一名特许金融分析师(CFA)。2017年,本斯勒与他人共同创立了一家教育科技课程管理和安排公司,该公司被植入加拿大和美国的学术学校。从2017年到2019年,本斯勒在一家领先的加拿大投资者关系公司担任客户经理,在那里他代表各行各业的上市公司,直接与投资银行、投资经纪人以及公司高管和董事合作。在任职期间,本斯勒创建并传达了有关其客户在市场中的战略地位的信息,并成功地指导了多家公司通过多次融资。从2019年到2021年,本斯勒在加拿大精品投行Evans & Evans担任高级助理,负责加拿大和美国公司的估值和上市交易。在担任这一职务期间,本斯勒先生对资本市场、上市公司合规要求有了很深的了解,并定期与监管机构、审计员、董事会和执行管理层进行交流。自2020年以来,本斯勒还担任上市公司Health Logic Interactive Inc.(TSXv:CHIP)的董事。我们相信,Bensler先生过去担任Elevai Labs,Inc. 首席财务官的经验,他对银行和金融咨询行业的熟悉,以及他曾在类似情况的公司担任客户经理,使他成为Elevai Labs,Inc.公司的合格董事。本斯勒在西安大略大学获得管理和组织研究学士学位,专攻金融,是CFA特许持有人。
Graydon Bensler has served as Pmgc Holdings Inc.'s Chief Executive Officer since June 2024 and Chief Financial Officer since inception and a director since June 9, 2020. Mr. Bensler is a financial professional and analyst with over eight years of experience in financial consulting and management for both private businesses and US/Canadian publicly traded companies and is a CFA Charterholder (CFA). Mr. Bensler is the founder and sole owner of GB Capital Ltd, a privately held holding company he founded in 2019 and which company is engaged in capital markets advisory, financial consulting, and management. In 2017, Mr. Bensler co founded an education technology curriculum management and scheduling company that was implemented in academic schools in Canada and the United States. From 2017 to 2019, Mr. Bensler was an account manager at a leading Canadian investor relations firm where he represented publicly traded companies across a wide range of sectors and worked directly with investment banks, investment brokers and company executives and directors. During his tenure at this investor relations firm, Mr. Bensler created and conveyed messaging about his clients' strategic position in the market and successfully guided several companies through multiple financings. From 2019 to 2021, Mr. Bensler was a Senior Associate at Evans & Evans, a Canadian boutique investment banking firm where he led valuations and going public transactions for Canadian and United States companies. In this capacity, Mr. Bensler gained strong knowledge of the capital markets, public company compliance requirements, and regularly interfaced with regulators, auditors, board and executive management.
Braeden Lichti

Braeden Lichti是加拿大公民。股票期权授予Lichti先生,作为对其为发行人提供服务的补偿。


Braeden Lichti has served as Non Executive Chairman of the Board from June 21, 2024 to the present. Mr. Lichti, together with his organization NorthStrive Companies Inc, led the restructuring and repositioning of what was formerly Elevai Labs into PMGC, a diversified public holding company focused on acquiring and scaling operating businesses.Mr. Lichti has served as Chief Executive Officer of BWL Investments Ltd., a privately held investment and holding company, since its founding in 2016. He is also the Founder and Chief Executive Officer of NorthStrive Companies, Inc., a U.S. based investment and advisory firm, since 2021.From October 8, 2024 to November 17, 2025, Mr. Lichti served as a member of the Board of Directors of Qualigen Therapeutics, Inc. (NASDAQ:QLGN). During his tenure, the Company completed a $41 million private investment in public equity (PIPE) financing led by Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI), resulting in a change of control, board reconstitution, and a strategic transformation of the business toward a new operating model.Mr. Lichti has also been involved with Hydromer, Inc. (OTC:HYDI), where Northstrive Companies Inc. was an advisor and significant shareholder. During this period, the Company secured a strategic investment from jMedtech, a global medical device company, resulting in a change of control, board reconstitution, and the establishment of an expanded international platform within the medical device coatings industry.Mr. Lichti has over a decade of experience in public markets, mergers and acquisitions, capital formation, and corporate restructuring. He has been directly involved in multiple public company transactions, including initial public offerings, reverse mergers, recapitalizations, and strategic investments.
Braeden Lichti是加拿大公民。股票期权授予Lichti先生,作为对其为发行人提供服务的补偿。
Braeden Lichti has served as Non Executive Chairman of the Board from June 21, 2024 to the present. Mr. Lichti, together with his organization NorthStrive Companies Inc, led the restructuring and repositioning of what was formerly Elevai Labs into PMGC, a diversified public holding company focused on acquiring and scaling operating businesses.Mr. Lichti has served as Chief Executive Officer of BWL Investments Ltd., a privately held investment and holding company, since its founding in 2016. He is also the Founder and Chief Executive Officer of NorthStrive Companies, Inc., a U.S. based investment and advisory firm, since 2021.From October 8, 2024 to November 17, 2025, Mr. Lichti served as a member of the Board of Directors of Qualigen Therapeutics, Inc. (NASDAQ:QLGN). During his tenure, the Company completed a $41 million private investment in public equity (PIPE) financing led by Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI), resulting in a change of control, board reconstitution, and a strategic transformation of the business toward a new operating model.Mr. Lichti has also been involved with Hydromer, Inc. (OTC:HYDI), where Northstrive Companies Inc. was an advisor and significant shareholder. During this period, the Company secured a strategic investment from jMedtech, a global medical device company, resulting in a change of control, board reconstitution, and the establishment of an expanded international platform within the medical device coatings industry.Mr. Lichti has over a decade of experience in public markets, mergers and acquisitions, capital formation, and corporate restructuring. He has been directly involved in multiple public company transactions, including initial public offerings, reverse mergers, recapitalizations, and strategic investments.
Rick L. Sterling

Rick L. Sterling,他是首席财务官。2007年以来,他一直担任Aquabounty Technologies, Inc.的首席财务官。加入Aquabounty Technologies, Inc.之前,他曾任职KPMG公司,在那里他曾从事审计执业17年以上,其主要客户群是在医疗保健、科技和制造业。他拥有私人和公共部门客户服务经验,包括SEC备案文件和萨班斯-奥克斯利法案合规的丰富经验。他持有 Virginia Polytechnical Institute和State University的会计和财务学士学位。他是注册会计师。


Rick L. Sterling,has served on the Board of AquaBounty since September 2013. He served as the Chief Financial Officer at Precigen Inc. (NASDAQ:PGEN) ("Precigen") from 2007 through March 2021, including leading them through their initial public offering in 2013. During his term at Precigen, Mr. Sterling was responsible for multiple private and public equity and debt capital raises, financial diligence for and integration of over a dozen acquisitions, SEC reporting and compliance, divestitures of businesses, budgeting, and negotiations of facility leases as well as oversight of human resource and information technology functions. Prior to joining Precigen, he was with KPMG where he worked in the audit practice for over 17 years, with a client base primarily in the healthcare, technology and manufacturing industries. He has a Bachelor of Science in Accounting from Virginia Tech and is a icensed Certified Public Accountant.
Rick L. Sterling,他是首席财务官。2007年以来,他一直担任Aquabounty Technologies, Inc.的首席财务官。加入Aquabounty Technologies, Inc.之前,他曾任职KPMG公司,在那里他曾从事审计执业17年以上,其主要客户群是在医疗保健、科技和制造业。他拥有私人和公共部门客户服务经验,包括SEC备案文件和萨班斯-奥克斯利法案合规的丰富经验。他持有 Virginia Polytechnical Institute和State University的会计和财务学士学位。他是注册会计师。
Rick L. Sterling,has served on the Board of AquaBounty since September 2013. He served as the Chief Financial Officer at Precigen Inc. (NASDAQ:PGEN) ("Precigen") from 2007 through March 2021, including leading them through their initial public offering in 2013. During his term at Precigen, Mr. Sterling was responsible for multiple private and public equity and debt capital raises, financial diligence for and integration of over a dozen acquisitions, SEC reporting and compliance, divestitures of businesses, budgeting, and negotiations of facility leases as well as oversight of human resource and information technology functions. Prior to joining Precigen, he was with KPMG where he worked in the audit practice for over 17 years, with a client base primarily in the healthcare, technology and manufacturing industries. He has a Bachelor of Science in Accounting from Virginia Tech and is a icensed Certified Public Accountant.

高管简历

中英对照 |  中文 |  英文
David A. Frank

David A. Frank,他于2007年10月被任命为AquaBounty的首席财务官兼财务主管。此前,他曾担任TekCel LLC(Magellan Biosciences的子公司)的总裁兼总经理,此前曾担任Magellan公司的首席财务官(2004年公司创立以来),并担任TekCel公司的首席财务官。他拥有30年以上的财务管理经验,包括担任SmartEnergy(一个独立的能源供应商)的首席财务官、Moldflow Corporation的公司总会计师,以及PerSeptive Biosystems, Inc.、 Lotus Development Corporation、Apollo Computer, Inc.、Honeywell International, Inc的财务职务。他持有Boston College的财务和会计学士学位,以及Babson College的工商管理硕士学位。


David A. Frank,was appointed Interim Chief Executive Officer of AquaBounty on December 6, 2024, while retaining his positions as Chief Financial Officer and Treasurer of AquaBounty since October 2007. Prior to joining AquaBounty, he served as Chief Financial Officer of Magellan Biosciences and President of TekCel between 2003 and 2007.
David A. Frank,他于2007年10月被任命为AquaBounty的首席财务官兼财务主管。此前,他曾担任TekCel LLC(Magellan Biosciences的子公司)的总裁兼总经理,此前曾担任Magellan公司的首席财务官(2004年公司创立以来),并担任TekCel公司的首席财务官。他拥有30年以上的财务管理经验,包括担任SmartEnergy(一个独立的能源供应商)的首席财务官、Moldflow Corporation的公司总会计师,以及PerSeptive Biosystems, Inc.、 Lotus Development Corporation、Apollo Computer, Inc.、Honeywell International, Inc的财务职务。他持有Boston College的财务和会计学士学位,以及Babson College的工商管理硕士学位。
David A. Frank,was appointed Interim Chief Executive Officer of AquaBounty on December 6, 2024, while retaining his positions as Chief Financial Officer and Treasurer of AquaBounty since October 2007. Prior to joining AquaBounty, he served as Chief Financial Officer of Magellan Biosciences and President of TekCel between 2003 and 2007.